The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
Status:
Terminated
Trial end date:
2016-04-08
Target enrollment:
Participant gender:
Summary
The hypothesis is that switching calcium based phosphate binders to sevelamer carbonate will
be associated with less inflammation including less atherosclerotic plaque inflammation
(inflammation of the vessel walls).